Table 1.
Characteristics of patients in the three groups.
| Mean & standard deviation or median & range |
NASH group N = 42 |
Steatosis group N = 47 |
Control group N = 50 |
P value NASH vs control | P value steatosis vs control | P value steatosis vs NASH |
|---|---|---|---|---|---|---|
| Male/female | 12/30 | 13/34 | 9/41 | 0.210 | 0.213 | 0.974 |
| Age | 46.9 ± 9.6 | 41.0 ± 8.7 | 35.1 ± 13.0 | 0.000 | 0.012 | 0.003 |
| BMI (kg/m2) | 31.5 ± 5.5 | 32.0 ± 5.2 | 29.5 ± 4.8 | 0.88 | 0.019 | 0.657 |
| Hemoglobin (g/l) | 129 (108–158) | 132 (78–174) | 130 (97–166) | 0.485 | 0.467 | 0.995 |
| Platelets (109/L) | 266 (204–426) | 276 (179–746) | 284 (141–475) | 0.237 | 1.000 | 0.213 |
| ALT (U/L) | 34 (17–127) | 37 (12–76) | 31 (19–112) | 0.005 | 0.453 | 0.053 |
| Albumin (mg/L) | 37.5 (29–44) | 38 (30–45) | 37 (27–44) | 0.444 | 0.801 | 0.341 |
| Bilirubin (µmol/L) | 7.5 (2.5–38) | 6 (2–18) | 6.2 (2–15) | 0.271 | 0.567 | 0.156 |
| INR | 1 (0.9–1.2) | 1 (0.9–1.1) | 1 (0.9–1.2) | 0.282 | 0.372 | 0.125 |
| Ferritin (µg/l) | 60.2 (4.6–263) | 51 (6–364) | 25.4 (8–348) | 0.007 | 0.014 | 0.767 |
| Cholesterol (mmol/L) | 5.2 (3.4–9.9) | 4.9 (3–7.3) | 4.8 (3–7.4) | 0.239 | 0.168 | 0.705 |
| Triglycerides (mmol/L) | 1.5 (0.6–8.0) | 1.2 (0.7–3.1) | 0.9 (0.2–2.7) | 0.002 | 0.001 | 0.885 |
|
Flow-mediated dilatation (%) |
6% (0–38) | 9.3 (0–40) | 13.6% (0–50) | 0.027 | 0.145 | 0.322 |